2314

112 / 6. 5~ 6. 11

學習

臨床藥學大觀園
《論藥之道》
Romosozumab
每月注射一次治療骨質疏鬆(下)

 

 


檢驗項目參考值:


BUN(blood urea nitrogen): 7-20 mg/dL; SCr(serum creatinine): male: 0.7-1.5 mg/dL; female: 0.5-1.2 mg/dL; CCr(creatinine clearance rate): >60 mL/min; ALT(alanine aminotransferase): 0-40 U/L; AST(aspartate aminotransferase): 5-45 U/L; T score:≧-2.5


參考資料:


1.Feskanich D, Willett W, Colditz G. Walking and leisure-time activity and risk of hip fracture in postmenopausal women. JAMA 2002; 288:2300-6.
2.Cosman F, Crittenden DB, Adachi JD, et al. Romosozumab treatment in postmenopausal women with osteoporosis. N Engl J Med 2016; 375:1532-34.


(全文完)


(本文作者為臺北榮民總醫院藥學部臨床藥師 / 陽明大學藥理所碩士)

 

 

回首頁